Literature DB >> 130905

Evidence for degradation of heparan sulfate by endoglycosidases: glucosamine and hexuronic acid are reducing terminals of intracellular heparan sulfate from human skin fibroblasts.

U Klein, H Kresse, K von Figura.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 130905     DOI： 10.1016/s0006-291x(76)80286-0

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN： 0006-291X            Impact factor:   3.575


× No keyword cloud information.
  8 in total

1.  Evidence that platelet and tumour heparanases are similar enzymes.

Authors:  C Freeman; A M Browne; C R Parish
Journal:  Biochem J       Date:  1999-09-01       Impact factor: 3.857

2.  Sanfilippo syndrome type C: deficiency of acetyl-CoA:alpha-glucosaminide N-acetyltransferase in skin fibroblasts.

Authors:  U Klein; H Kresse; K von Figura
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

3.  Human platelet heparanase: purification, characterization and catalytic activity.

Authors:  C Freeman; C R Parish
Journal:  Biochem J       Date:  1998-03-15       Impact factor: 3.857

4.  Stimulation of heparan sulphate synthesis in cultured rat hepatocytes by (+)-catechin.

Authors:  W Sinn; P R Sudhakaran; K Von Figura
Journal:  Biochem J       Date:  1981-10-15       Impact factor: 3.857

5.  The catabolism of intravenously injected heparan N-[35S] sulphate in the rat.

Authors:  M A Perry; G M Powell; F S Wusteman; C G Curtis
Journal:  Biochem J       Date:  1977-09-15       Impact factor: 3.857

6.  Heparan sulphate-degrading endoglycosidase in liver plasma membranes.

Authors:  J T Gallagher; A Walker; M Lyon; W H Evans
Journal:  Biochem J       Date:  1988-03-15       Impact factor: 3.857

7.  Sanfilippo disease type D: deficiency of N-acetylglucosamine-6-sulfate sulfatase required for heparan sulfate degradation.

Authors:  H Kresse; E Paschke; K von Figura; W Gilberg; W Fuchs
Journal:  Proc Natl Acad Sci U S A       Date:  1980-11       Impact factor: 11.205

8.  A rechargeable anti-thrombotic coating for blood-contacting devices.

Authors:  Hyun Ok Ham; Carolyn A Haller; Guowei Su; Erbin Dai; Madhukar S Patel; David R Liu; Jian Liu; Elliot L Chaikof
Journal:  Biomaterials       Date:  2021-07-09       Impact factor: 15.304
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.